dpp4 and glp 1 Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment Acute DPP-4 inhibition modulates vascular
Description
Initially indicated for type 2 diabetes mellitus, Tirzepatide promotes glycemic control and weight loss through incretin-mediated insulin secretion and appetite suppression
Truveta Research explores how the use of GLP-1 medications like semaglutide and tirzepatide is rapidly increasing among women with PCOS.
The Trump administration's most-favored-nation policy is delivering historic savings.
Regulatory submission for retatrutide is expected in 2026
